BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34445451)

  • 1. Prognostic Impact of Membranous/Nuclear Epidermal Growth Factor Receptor Localization in Clear Cell Renal Cell Carcinoma.
    Muroni MR; Ribback S; Sotgiu G; Kroeger N; Saderi L; Angius A; Cossu-Rocca P; De Miglio MR
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
    Jung M; Lee C; Park JH; Moon KC
    Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma.
    Dorđević G; Matušan Ilijaš K; Hadžisejdić I; Maričić A; Grahovac B; Jonjić N
    J Biomed Sci; 2012 Apr; 19(1):40. PubMed ID: 22475688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.
    Cohen D; Lane B; Jin T; Magi-Galluzzi C; Finke J; Rini BI; Bukowski RM; Zhou M
    Clin Genitourin Cancer; 2007 Mar; 5(4):264-70. PubMed ID: 17553206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
    Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
    BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
    Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
    Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of pregnancy up-regulated non-ubiquitous calmodulin kinase is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu S; Lv Z; Wang Y; Sun L; Jiang Z; Xu C; Zhao J; Sun X; Li X; Hu L; Tang A; Gui Y; Zhou F; Cai Z; Wang R
    PLoS One; 2013; 8(4):e59936. PubMed ID: 23634203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma.
    Kallio JP; Hirvikoski P; Helin H; Kellokumpu-Lehtinen P; Luukkaala T; Tammela TL; Martikainen PM
    Br J Cancer; 2003 Oct; 89(7):1266-9. PubMed ID: 14520458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma.
    Cossu-Rocca P; Muroni MR; Sanges F; Sotgiu G; Asunis A; Tanca L; Onnis D; Pira G; Manca A; Dore S; Uras MG; Ena S; De Miglio MR
    Am J Cancer Res; 2016; 6(1):71-83. PubMed ID: 27073724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
    Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
    Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
    Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.
    Hanabata Y; Nakajima Y; Morita K; Kayamori K; Omura K
    Odontology; 2012 Jul; 100(2):156-63. PubMed ID: 21607591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
    Lebdai S; Verhoest G; Parikh H; Jacquet SF; Bensalah K; Chautard D; Rioux Leclercq N; Azzouzi AR; Bigot P
    Urol Oncol; 2015 Feb; 33(2):69.e11-8. PubMed ID: 25035170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.
    Niu T; Liu Y; Zhang Y; Fu Q; Liu Z; Wang Z; Fu H; Xu J; Liu K
    Oncotarget; 2016 Aug; 7(31):50017-50026. PubMed ID: 27374181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
    Zaman S; Hajiran A; Coba GA; Robinson T; Madanayake TW; Segarra DT; Chobrutskiy BI; Boyle TA; Zhou JM; Kim Y; Mulé JJ; Teer JK; Manley BJ
    Eur Urol Focus; 2021 Mar; 7(2):373-380. PubMed ID: 31901438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
    Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
    J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.